NOT KNOWN FACTS ABOUT HOW TO USE MOUNJARO

one) and Drug Interactions (7)]. The potential risk of hypoglycemia could be reduced by a reduction within the dose of sulfonylurea (or other concomitantly administered insulin secretagogue) or insulin. Advise individuals working with these concomitant prescription drugs of the chance of hypoglycemia and educate them within the indicators and indic